• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学:SREBP 内含子使 HDL 微小 RNA 下调。

Medicine. HDL miR-ed down by SREBP introns.

机构信息

Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

出版信息

Science. 2010 Jun 18;328(5985):1495-6. doi: 10.1126/science.1192409.

DOI:10.1126/science.1192409
PMID:20558698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2936826/
Abstract

Animal cells must maintain a membrane cholesterol-to-phospholipid ratio within tight limits for normal function. Elaborate mechanisms control the cellular input of cholesterol from endogenous synthesis or uptake from plasma lipoproteins. Much less is known about the factors that regulate the output of cholesterol from cells. On pages 1566 and 1570 of this issue, Najafi-Shoushtari et al. (1) and Rayner et al. (2) show that cholesterol output is controlled by the same genes that regulate cholesterol input, but in a reciprocal manner and through an unexpected mechanism.

摘要

动物细胞必须将膜胆固醇与磷脂的比例维持在严格的范围内,以维持正常功能。复杂的机制控制着胆固醇从内源性合成或从血浆脂蛋白摄取进入细胞。关于调节细胞内胆固醇输出的因素知之甚少。在本期的 1566 页和 1570 页上,Najafi-Shoushtari 等人(1)和 Rayner 等人(2)表明,胆固醇的输出受调节胆固醇摄取的相同基因控制,但以一种相反的方式,并通过一种意想不到的机制。

相似文献

1
Medicine. HDL miR-ed down by SREBP introns.医学:SREBP 内含子使 HDL 微小 RNA 下调。
Science. 2010 Jun 18;328(5985):1495-6. doi: 10.1126/science.1192409.
2
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.miRNA-33 与 SREBP 宿主基因共同调控胆固醇稳态。
Science. 2010 Jun 18;328(5985):1566-9. doi: 10.1126/science.1189123. Epub 2010 May 13.
3
MiR-33 contributes to the regulation of cholesterol homeostasis.miR-33 有助于胆固醇稳态的调节。
Science. 2010 Jun 18;328(5985):1570-3. doi: 10.1126/science.1189862. Epub 2010 May 13.
4
Methyl protodioscin increases ABCA1 expression and cholesterol efflux while inhibiting gene expressions for synthesis of cholesterol and triglycerides by suppressing SREBP transcription and microRNA 33a/b levels.原薯蓣皂苷元通过抑制固醇调节元件结合蛋白(SREBP)转录及微小RNA 33a/b水平,增加ATP结合盒转运体A1(ABCA1)表达和胆固醇流出,同时抑制胆固醇和甘油三酯合成的基因表达。
Atherosclerosis. 2015 Apr;239(2):566-70. doi: 10.1016/j.atherosclerosis.2015.02.034. Epub 2015 Feb 23.
5
miR-33 links SREBP-2 induction to repression of sterol transporters.miR-33 将 SREBP-2 的诱导与固醇转运蛋白的抑制联系起来。
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12228-32. doi: 10.1073/pnas.1005191107. Epub 2010 Jun 21.
6
Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis.促凋亡 miRNA-128-2 调节 ABCA1、ABCG1 和 RXRα 的表达和胆固醇稳态。
Cell Death Dis. 2013 Aug 29;4(8):e780. doi: 10.1038/cddis.2013.301.
7
The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2.核受体FXR使miR-33的作用与SREBP-2解偶联。
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):787-95. doi: 10.1161/ATVBAHA.114.304179. Epub 2015 Jan 15.
8
MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo.Srebp2 内含子编码的 microRNA-33 可在体内调节 HDL。
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17321-6. doi: 10.1073/pnas.1008499107. Epub 2010 Sep 20.
9
MicroRNAs regulating lipid metabolism in atherogenesis.微小 RNA 调节动脉粥样硬化中的脂质代谢。
Thromb Haemost. 2012 Apr;107(4):642-7. doi: 10.1160/TH11-10-0694. Epub 2012 Jan 25.
10
MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.MicroRNA-33 调控小鼠固醇调节元件结合蛋白 1 的表达。
Nat Commun. 2013;4:2883. doi: 10.1038/ncomms3883.

引用本文的文献

1
Key events in cancer: Dysregulation of SREBPs.癌症中的关键事件:固醇调节元件结合蛋白的失调
Front Pharmacol. 2023 Mar 8;14:1130747. doi: 10.3389/fphar.2023.1130747. eCollection 2023.
2
Role of miR-181c in Diet-induced obesity through regulation of lipid synthesis in liver.miR-181c 通过调控肝脏脂质合成在饮食诱导肥胖中的作用。
PLoS One. 2021 Dec 8;16(12):e0256973. doi: 10.1371/journal.pone.0256973. eCollection 2021.
3
miR-33 in cardiometabolic diseases: lessons learned from novel animal models and approaches.miR-33 在心脏代谢疾病中的作用:新型动物模型和方法的启示。
EMBO Mol Med. 2021 May 7;13(5):e12606. doi: 10.15252/emmm.202012606. Epub 2021 May 3.
4
Functional non-coding RNAs in vascular diseases.血管疾病中的功能性非编码 RNA。
FEBS J. 2021 Nov;288(22):6315-6330. doi: 10.1111/febs.15678. Epub 2021 Jan 7.
5
MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease.微小 RNA 作为一种新型工具在肝脂质失调和脂肪肝疾病诊断中的应用。
Molecules. 2019 Jan 9;24(2):230. doi: 10.3390/molecules24020230.
6
Increased expression of miR-33a in monocytes from Mexican hypertensive patients in elevated carotid intima-media thickness.在颈动脉内膜中层厚度升高的墨西哥高血压患者的单核细胞中,miR-33a 的表达增加。
J Hum Hypertens. 2018 Oct;32(10):681-690. doi: 10.1038/s41371-018-0102-x. Epub 2018 Sep 19.
7
SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond.固醇调节元件结合蛋白在脂代谢、胰岛素信号转导及其他方面的作用
Trends Biochem Sci. 2018 May;43(5):358-368. doi: 10.1016/j.tibs.2018.01.005. Epub 2018 Feb 27.
8
Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia.2型糖尿病合并血脂异常患者血浆微小RNA33b检测的临床意义
J Atheroscler Thromb. 2016 Nov 1;23(11):1276-1285. doi: 10.5551/jat.33670. Epub 2016 Jun 15.
9
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.肥胖相关性肾小球病:临床与病理特征及发病机制。
Nat Rev Nephrol. 2016 Aug;12(8):453-71. doi: 10.1038/nrneph.2016.75. Epub 2016 Jun 6.
10
SREBP-1c/MicroRNA 33b Genomic Loci Control Adipocyte Differentiation.SREBP-1c/微小RNA 33b基因组位点控制脂肪细胞分化。
Mol Cell Biol. 2016 Feb 1;36(7):1180-93. doi: 10.1128/MCB.00745-15.

本文引用的文献

1
MiR-33 contributes to the regulation of cholesterol homeostasis.miR-33 有助于胆固醇稳态的调节。
Science. 2010 Jun 18;328(5985):1570-3. doi: 10.1126/science.1189862. Epub 2010 May 13.
2
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.miRNA-33 与 SREBP 宿主基因共同调控胆固醇稳态。
Science. 2010 Jun 18;328(5985):1566-9. doi: 10.1126/science.1189123. Epub 2010 May 13.
3
Mouse models of the metabolic syndrome.代谢综合征的小鼠模型。
Dis Model Mech. 2010 Mar-Apr;3(3-4):156-66. doi: 10.1242/dmm.003467.
4
ABCA1: at the nexus of cholesterol, HDL and atherosclerosis.ABCA1:处于胆固醇、高密度脂蛋白与动脉粥样硬化的关联之中。
Trends Biochem Sci. 2007 Apr;32(4):172-9. doi: 10.1016/j.tibs.2007.02.001. Epub 2007 Feb 26.
5
Fatty acid auxotrophy in Drosophila larvae lacking SREBP.缺乏固醇调节元件结合蛋白的果蝇幼虫中的脂肪酸营养缺陷型
Cell Metab. 2006 Jun;3(6):439-48. doi: 10.1016/j.cmet.2006.04.011.
6
Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome.为什么是X综合征?从哈罗德·辛姆斯沃思到胰岛素抵抗综合征。
Cell Metab. 2005 Jan;1(1):9-14. doi: 10.1016/j.cmet.2004.12.001.
7
Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.肝脏X受体在胰岛素介导的Srebp-1c转录激活及肝脏脂肪酸合成刺激中起核心作用。
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11245-50. doi: 10.1073/pnas.0404297101. Epub 2004 Jul 20.
8
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.固醇调节元件结合蛋白:肝脏中胆固醇和脂肪酸合成完整程序的激活剂。
J Clin Invest. 2002 May;109(9):1125-31. doi: 10.1172/JCI15593.
9
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.氧甾醇受体LXRα和LXRβ对小鼠固醇调节元件结合蛋白-1c基因(SREBP-1c)的调控
Genes Dev. 2000 Nov 15;14(22):2819-30. doi: 10.1101/gad.844900.
10
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.固醇调节元件结合蛋白(SREBP)途径:通过膜结合转录因子的蛋白水解作用调节胆固醇代谢
Cell. 1997 May 2;89(3):331-40. doi: 10.1016/s0092-8674(00)80213-5.